UPDATE: FluimediX Closes $1.1M Financing Round

The Danish firm, which is developing a rapid, point-of-care molecular diagnostic platform, raised $1.1 million in the round.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories